Hims & Hers Health (HIMS) Cash & Current Investments (2019 - 2026)
Hims & Hers Health's (HIMS) quarterly Cash & Current Investments came in at $750.9 million in Q1 2026, up 132.71% year-on-year from $322.7 million in Q1 2025, and up 30.02% quarter-over-quarter from $577.5 million in Q4 2025.
Hims & Hers Health (HIMS) Cash & Current Investments (2019 - 2026) Analysis & Trends
Hims & Hers Health has disclosed Cash & Current Investments across 8 years of filings, most recently posting $750.9 million for Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $750.9 million, up 132.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $750.9 million (up 132.71% YoY), and the FY2025 annual result was $577.5 million, up 92.34% from the prior year.
- Cash & Current Investments came in at $750.9 million for Q1 2026 at Hims & Hers Health, up from $577.5 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $1.1 billion in Q2 2025 to a low of $179.6 million in Q4 2022.
- The 5-year median for Cash & Current Investments is $221.0 million (2023), against an average of $352.8 million.
- Across the five-year window, Cash & Current Investments sank 38.56% in 2022 and soared 403.59% in 2025, its largest moves.
- Hims & Hers Health's Cash & Current Investments stood at $179.6 million in 2022, then rose by 23.02% to $221.0 million in 2023, then soared by 35.87% to $300.3 million in 2024, then jumped by 92.34% to $577.5 million in 2025, then soared by 30.02% to $750.9 million in 2026.
- The last three Cash & Current Investments figures came in at $750.9 million (Q1 2026), $577.5 million (Q4 2025), and $629.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 498.58 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 750.88 Mn |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 222.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 750.88 Mn |
| Dec 31, 2025 | 577.49 Mn |
| Sep 30, 2025 | 629.74 Mn |
| Jun 30, 2025 | 1.14 Bn |
| Mar 31, 2025 | 322.67 Mn |
| Dec 31, 2024 | 300.25 Mn |
| Sep 30, 2024 | 254.07 Mn |
| Jun 30, 2024 | 227.29 Mn |
| Mar 31, 2024 | 203.59 Mn |
| Dec 31, 2023 | 220.98 Mn |
| Sep 30, 2023 | 212.50 Mn |
| Jun 30, 2023 | 193.14 Mn |
| Mar 31, 2023 | 184.39 Mn |
| Dec 31, 2022 | 179.63 Mn |
| Sep 30, 2022 | 198.39 Mn |
| Jun 30, 2022 | 194.98 Mn |
| Mar 31, 2022 | 203.05 Mn |
| Dec 31, 2021 | 247.27 Mn |
| Sep 30, 2021 | 252.43 Mn |
| Jun 30, 2021 | 317.32 Mn |